Sohonos

Active Ingredient(s): Palovarotene
FDA Approved: * August 16, 2023
Pharm Company: * IPSEN INC
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Sohonos 1 mg Oral Capsule
NDC: 15054-0010
Labeler:
Ipsen Biopharmaceuticals, Inc.
Sohonos 1.5 mg Oral Capsule
NDC: 15054-0015
Labeler:
Ipsen Biopharmaceuticals, Inc.
Sohonos 2.5 mg Oral Capsule
NDC: 15054-0025
Labeler:
Ipsen Biopharmaceuticals, Inc.
Sohonos 5 mg Oral Capsule
NDC: 15054-0050
Labeler:
Ipsen Biopharmaceuticals, Inc.
Sohonos 10 mg Oral Capsule
NDC: 15054-0100
Labeler:
Ipsen Biopharmaceuticals, Inc.